Fermenta Biotech informs about revised earnings presentation

01 Jun 2022 Evaluate

With reference to its intimation dated May 31, 2022 regarding Earnings Presentation for Quarter 4- Financial Year 2021-2022, Fermenta Biotech has informed that there was a typographical error on page 6 – para 2 ‘Q4-FY22 Operational Highlights’ of the said Earnings Presentation. In view of above, the company has enclosed the revised Earnings Presentation for Quarter 4- Financial Year 2021-2022 for the record. Except the said revision on page 6- para 2 ‘Q4-FY22 Operational Highlights’, all other details remain unchanged. The revised Earnings Presentation will thereafter be uploaded on Company’s website at www.fermentabiotech.com.

The above information is a part of company’s filings submitted to BSE.


Fermenta Biotech Share Price

324.95 -1.05 (-0.32%)
22-Jan-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1634.40
Dr. Reddys Lab 1217.15
Cipla 1371.55
Zydus Lifesciences 884.85
Lupin 2165.05
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×